27 related articles for article (PubMed ID: 24763036)
1. A key to engineering natural killer cells to attack acute myeloid leukemia.
Masamoto Y; Kurokawa M
Haematologica; 2024 Apr; 109(4):1032-1034. PubMed ID: 37916393
[No Abstract] [Full Text] [Related]
2. Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.
Noguchi Y; Tomizawa D; Hiroki H; Miyamoto S; Tezuka M; Miyawaki R; Tanaka-Kubota M; Okano T; Kobayashi C; Mitsuiki N; Aoki Y; Imai K; Kajiwara M; Kanegane H; Morio T; Takagi M
Clin Case Rep; 2018 Jun; 6(6):1023-1028. PubMed ID: 29881556
[TBL] [Abstract][Full Text] [Related]
3. New horizons for natural killer cell research in cancer, infection and inflammation.
Souza-Fonseca-Guimaraes F
Clin Transl Immunology; 2021; 10(4):e1275. PubMed ID: 33959280
[TBL] [Abstract][Full Text] [Related]
4. Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis.
Ogura K; Kimura F; Kobayashi S; Torikai H; Ikeda T; Sato K; Motoyoshi K
Leuk Res; 2006 Jun; 30(6):761-3. PubMed ID: 16140376
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias.
Cruse JM; Lewis RE; Pierce S; Lam J; Tadros Y
Exp Mol Pathol; 2005 Aug; 79(1):39-41. PubMed ID: 16005710
[TBL] [Abstract][Full Text] [Related]
6. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
7. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
8. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
[TBL] [Abstract][Full Text] [Related]
9. [Myeloid/natural killer cell precursor and myeloid/natural killer cell acute leukemia].
Ni M; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):525-9. PubMed ID: 24763036
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of acute myelogenous leukemia].
Aul C; Fischer JT; Schneider W
Onkologie; 1983 Dec; 6(6):280-6. PubMed ID: 6366672
[TBL] [Abstract][Full Text] [Related]
11. [Leukemia: recent progress in diagnosis and treatment. Topics: III. Diagnosis and treatments; 1. Treatment for adult acute myeloid leukemia].
Usui N
Nihon Naika Gakkai Zasshi; 2013 Jul; 102(7):1687-95. PubMed ID: 23947230
[No Abstract] [Full Text] [Related]
12. Morphologic basis for the MIC classification in acute myeloid leukemia.
Löffler H
Recent Results Cancer Res; 1993; 131():339-43. PubMed ID: 8210652
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
